Association of Proton Pump Inhibitors with Increased Risk of Spontaneous Bacterial Peritonitis in Patients with Decompensated Chronic Liver Disease: Analytical Cross-Sectional Study

Objective: To look for a possible association between the use of proton pump inhibitors and the development of spontaneous bacterial peritonitis in patients with decompensated chronic liver disease and to draw a comparison between decompensated chronic liver disease patients who are using PPIs and those who are not using them.Study Design: Analytical cross-sectional study.Place and Duration of Study: This study was conducted at the Department of Gastroenterology, Combined Military Hospital (CMH), Lahore, Pakistan, from 5th June 2023 to 4th December 2023.Methods: Patients were divided into two groups. The first group included all patients with decompensated chronic liver disease who were taking PPIs, and the second group included all decompensated chronic liver disease patients who were not taking PPIs at the time of development of Spontaneous bacterial peritonitis. Written informed consent was obtained from all patients in both groups. Inclusion Criteria included patients of the age group ranging from 30 to 80 years having confirmed liver cirrhosis along with splenomegaly and ascites on abdominal ultrasound. Exclusion Criteria included all patients with a history of Child Pugh Class A chronic liver disease, patients with alcohol intake, and patients with gastrointestinal malignancy.Results: Among diagnosed cases of decompensated chronic liver cirrhosis, the rate of development of spontaneous bacterial peritonitis was 7.58 % in patients using proton pump inhibitors as compared to 1.7 % among patients with chronic liver disease who were not using proton pump inhibitors, with a significant P-value of 0.01.Conclusion: Use of proton pump inhibitors significantly increased the likelihood of developing spontaneous bacterial peritonitis in decompensated chronic liver patients. How to cite this: Habib A, Uddin R, Khan R, Manzar MA, Malik A, Ashraf S. Association of Proton Pump Inhibitors with Increased Risk ofSpontaneous Bacterial Peritonitis in Patients with Decompensated Chronic Liver Disease: Analytical Cross-Sectional Study. Life andScience. 2026; 7(1): 106-111. doi: http://doi.org/10.37185/LnS.1.1.599

Authors

Institutions

Publication Details

Journal
Life and Science
Published
2026-02-09
DOI
https://doi.org/10.37185/lns.1.1.599
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Proton Pump Inhibitors with Increased Risk of Spontaneous Bacterial Peritonitis in Patients with Decompensated Chronic Liver Disease: Analytical Cross-Sectional Study

Ayesha Malik, Muhammad Adnan Manzar, Syra Ashraf, Raheel Khan et al.
Life and Science
Liver Disease and Transplantation
article

Association of Proton Pump Inhibitors with Increased Risk of Spontaneous Bacterial Peritonitis in Patients with Decompensated Chronic Liver Disease: Analytical Cross-Sectional Study

Ayesha Malik, Muhammad Adnan Manzar, Syra Ashraf, Raheel Khan, Aamir Habib, Rafi Uddin
article en

Abstract

Objective: To look for a possible association between the use of proton pump inhibitors and the development of spontaneous bacterial peritonitis in patients with decompensated chronic liver disease and to draw a comparison between decompensated chronic liver disease patients who are using PPIs and those who are not using them.Study Design: Analytical cross-sectional study.Place and Duration of Study: This study was conducted at the Department of Gastroenterology, Combined Military Hospital (CMH), Lahore, Pakistan, from 5th June 2023 to 4th December 2023.Methods: Patients were divided into two groups. The first group included all patients with decompensated chronic liver disease who were taking PPIs, and the second group included all decompensated chronic liver disease patients who were not taking PPIs at the time of development of Spontaneous bacterial peritonitis. Written informed consent was obtained from all patients in both groups. Inclusion Criteria included patients of the age group ranging from 30 to 80 years having confirmed liver cirrhosis along with splenomegaly and ascites on abdominal ultrasound. Exclusion Criteria included all patients with a history of Child Pugh Class A chronic liver disease, patients with alcohol intake, and patients with gastrointestinal malignancy.Results: Among diagnosed cases of decompensated chronic liver cirrhosis, the rate of development of spontaneous bacterial peritonitis was 7.58 % in patients using proton pump inhibitors as compared to 1.7 % among patients with chronic liver disease who were not using proton pump inhibitors, with a significant P-value of 0.01.Conclusion: Use of proton pump inhibitors significantly increased the likelihood of developing spontaneous bacterial peritonitis in decompensated chronic liver patients. How to cite this: Habib A, Uddin R, Khan R, Manzar MA, Malik A, Ashraf S. Association of Proton Pump Inhibitors with Increased Risk ofSpontaneous Bacterial Peritonitis in Patients with Decompensated Chronic Liver Disease: Analytical Cross-Sectional Study. Life andScience. 2026; 7(1): 106-111. doi: http://doi.org/10.37185/LnS.1.1.599

Life and ScienceVol. 7(1)
Combined Military Hospital (PK)
Good health and well-being
Openalex Percentile: Top 47%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.